Publicacións nas que colabora con Lourdes Calvo Martínez (9)

2021

  1. Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer? (Virchows Archiv, (2021), 479, 4, (853-857), 10.1007/s00428-021-03104-7)

    Virchows Archiv

  2. Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

    Virchows Archiv, Vol. 479, Núm. 4, pp. 853-857

2019

  1. Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: Efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution

    Breast Cancer: Targets and Therapy, Vol. 11, pp. 29-42

2018

  1. Hakai overexpression effectively induces tumour progression and metastasis in vivo

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Clinical implications of epithelial cell plasticity in cancer progression

    Cancer Letters, Vol. 366, Núm. 1, pp. 1-10

2012

  1. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

    Journal of Translational Medicine, Vol. 10, Núm. 1

2011

  1. Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer

    International Journal of Oncology, Vol. 39, Núm. 5, pp. 1253-1264

2009

  1. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: A pilot study

    Journal of Cancer Research and Clinical Oncology, Vol. 135, Núm. 9, pp. 1185-1195

1996

  1. Cardiac osteogenic sarcoma with chondroblastic differentiation

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 13, Núm. 4, pp. 178-180